- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 14, 2024 | 301.09M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $1.25K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$1.18M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $249.88K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $120.72K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.12M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$2.21M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$2.09M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$1.47M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$1.71M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $2.76M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $3.44M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.76M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.44M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $551.84K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $1.35M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $554.46K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.35M |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $669.12K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $415.98K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$308.23K |
| Net Income | Q1 2024 · Dec 31, 2023 | −$1.03M |
| Net Income | Q1 2024 · Mar 31, 2023 | $234.28K |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$464.18K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $251.36K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $204.94K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $667.33K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $275.35K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $127.34K |
| Revenue | Q1 2024 · Mar 31, 2024 | $480.28K |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $794.67K |